home / stock / crpof / crpof quote
Last: | $0.183 |
---|---|
Change Percent: | 0.0% |
Open: | $0.183 |
Close: | $0.183 |
High: | $0.183 |
Low: | $0.183 |
Volume: | 3,000 |
Last Trade Date Time: | 05/13/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.183 | $0.183 | $0.183 | $0.183 | $0.183 | 3,000 | 05-13-2024 |
$0.183 | $0.183 | $0.183 | $0.183 | $0.183 | 13,000 | 05-10-2024 |
$0.1845 | $0.1845 | $0.1845 | $0.1845 | $0.1845 | 650 | 04-22-2024 |
$0.1771 | $0.180628 | $0.1771 | $0.180628 | $0.1771 | 6,451 | 04-15-2024 |
$0.181313 | $0.181313 | $0.181313 | $0.181313 | $0.181313 | 500 | 04-11-2024 |
$0.1829 | $0.1829 | $0.1829 | $0.1829 | $0.1829 | 1,000 | 04-04-2024 |
$0.17501 | $0.17501 | $0.17501 | $0.17501 | $0.17501 | 1,400 | 04-03-2024 |
$0.1669 | $0.1669 | $0.1669 | $0.1669 | $0.1669 | 5,000 | 03-26-2024 |
$0.17095 | $0.166947 | $0.17095 | $0.17095 | $0.166947 | 193,500 | 03-25-2024 |
$0.1618 | $0 | $0.1618 | $0 | $0 | 30 | 03-14-2024 |
$0.1618 | $0.1619 | $0.1618 | $0.1619 | $0.1618 | 41,000 | 03-08-2024 |
$0.17338 | $0.17565 | $0.17338 | $0.17565 | $0.17338 | 29,000 | 03-07-2024 |
$0.16758 | $0.16758 | $0.16758 | $0.16758 | $0.16758 | 10,000 | 03-06-2024 |
$0.17775 | $0.17775 | $0.17775 | $0.17775 | $0.17775 | 30,000 | 03-04-2024 |
$0.1634 | $0.1634 | $0.1634 | $0.1634 | $0.1634 | 5,000 | 03-01-2024 |
$0.16 | $0 | $0.16 | $0 | $0 | 22 | 02-29-2024 |
$0.16 | $0.155 | $0.16 | $0.1611 | $0.153 | 20,220 | 02-28-2024 |
$0.155 | $0.1613 | $0.155 | $0.1613 | $0.155 | 61,500 | 02-27-2024 |
$0.1564 | $0.17705 | $0.1564 | $0.17705 | $0.1564 | 41,570 | 02-26-2024 |
$0.12182 | $0 | $0.12182 | $0 | $0 | 15,000 | 02-23-2024 |
News, Short Squeeze, Breakout and More Instantly...
– 2023 marked by Ceapro’s achievement of key milestones and progress toward its next phase of growth – R&D activities focused on advancement of avenanthramide Phase 1-2a clinical study and the processing of yeast beta glucan along with the building of pi...
TORONTO and EDMONTON, Alberta, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) ("Aeterna") and Ceapro ...
TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (" Aeterna ") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“ Ceapro ”) are pleased to announce that the Court of King's Bench of Alberta has issued a final order approvin...